1. Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy;Parrillo, J.E.; Parker, M.M.; Natanson, C.; Suffredini, A.F.; Danner, R.L.; Cunnion, R.E.;Ann Intern Med,1990
2. Patterns of septic shock in man-a detailed study of 56 patients;MacLean, L.D.; Mulligan, W.G.; McLean, A.P.H.; Duff, J.H.;Ann Surg,1967
3. Profound but reversible myocardial depression in patients with septic shock;Parker, M.M.; Shelhamer, J.H.; Bacharach, S.L.; Green, M.V.; Natanson, C.; Frederick, T.M.;Ann Intern Med,1984
4. Left ventricular performance in septic shock: Reversible segmental and global abnormalities;Ellrodt, A.G.; Riedinger, M.S.; Kimchi, A.; Berman, D.S.; Maddahi, J.; Swan, H.J.C.;Am HeartJ,1985
5. A controlled clinical trial of highdose methylprednisolone in the treatment of severe sepsis and septic shock;Bone, R.C.; Fisher, C.J.; Clemmer, T.P.; Slotman, G.J.; Metz, C.A.; Balk, R.A.;NEnglJMed,1987